TLR4 in Toxoplasmosis; friends or foe?

Microbial Pathogenesis

Volumn 69-70, Issue 1, 2014, Pages 28-32

  Zare Bidaki, Mohammad ^a   Hakimi, Hamid ^a   Abdollahi, Seyyed Hossein ^a   Zainodini, Nahid ^a   Kazemi Arababadi, Mohammad ^a   Kennedy, Derek ^b  

^a RAFSANJAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b GRIFFITH UNIVERSITY   (Australia)

Author keywords

Pathogen recognition receptor; Signaling molecule; TLR4; Toxoplasma

Indexed keywords

MYELOID DIFFERENTIATION FACTOR 88; TOLL LIKE RECEPTOR 4; TOLL LIKE RECEPTOR ADAPTOR MOLECULE 1; PATTERN RECOGNITION RECEPTOR; TLR4 PROTEIN, HUMAN;

ANTIGEN RECOGNITION; DISEASE ASSOCIATION; IMMUNE RESPONSE; INNATE IMMUNITY; INTRACELLULAR SIGNALING; LIGAND BINDING; MICROORGANISM DETECTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; REVIEW; SIGNAL TRANSDUCTION; TOXOPLASMA GONDII; TOXOPLASMOSIS; HUMAN; IMMUNOLOGY; PATHOLOGY; TOXOPLASMA;

HUMANS; RECEPTORS, PATTERN RECOGNITION; SIGNAL TRANSDUCTION; TOLL-LIKE RECEPTOR 4; TOXOPLASMA; TOXOPLASMOSIS;

EID: 84898888281     PISSN: 08824010     EISSN: 10961208     Source Type: Journal    
DOI: 10.1016/j.micpath.2014.03.006     Document Type: Review

References (51)

1. Abdollahi S.H., Ayoobi F., Khorramdelazad H., Hassanshahi G., Ahmadabadi B.N., Rezayati M., et al. Interleukin-10 serum levels after vaccination with invivo prepared Toxoplasma gondii excreted/secreted antigens. Oman Med J 2013, 28:112-115.
2. Montoya J.G., Liesenfeld O. Toxoplasmosis. Lancet 2004, 363:1965-1976.
3. Pusch L., Romeike B., Deckert M., Mawrin C. Persistent Toxoplasma bradyzoite cysts in the brain: incidental finding in an immunocompetent patient without evidence of a toxoplasmosis. Clin Neuropathol 2009, 28:210-212.
4. Jalallou N., Bandepour M., Khazan H., Haghighi A., Abdollahi S., Kazemi B. Recombinant SAG1 antigen to detect Toxoplasma gondii specific immunoglobulin G in human sera by ELISA test. Iran J Parasitol 2010, 5:1-9.
5. Dupont C.D., Christian D.A., Hunter C.A. Immune response and immunopathology during toxoplasmosis. Seminars in Immunopathology: Springer 2012, 793-813.
6. Medzhitov R., Preston-Hurlburt P., Janeway C.A. Ahuman homologue of the Drosophila Toll protein signals activation of adaptive immunity. Nature 1997, 388:394-397.
7. Botos I., Segal D.M., Davies D.R. The structural biology of Toll-like receptors. Structure 2011, 19:447-459.
8. Carpenter S., O'Neill L. Recent insights into the structure of Toll-like receptors and post-translational modifications of their associated signalling proteins. Biochem J 2009, 422:1-10.
9. Nguyen-Pham T.N., Lim M.S., Nguyen T.A., Lee Y.K., Jin C.J., Lee H.J., et al. Type I and II interferons enhance dendritic cell maturation and migration capacity by regulating CD38 and CD74 that have synergistic effects with TLR agonists. Cell Mol Immunol 2011, 8:341-347.
10. Hirayama T., Tamaki Y., Takakubo Y., Iwazaki K., Sasaki K., Ogino T., et al. Toll-like receptors and their adaptors are regulated in macrophages after phagocytosis of lipopolysaccharide-coated titanium particles. JOrthop Res 2011, 29:984-992.
11. Imani Fooladi A.A., Mousavi S.F., Seghatoleslami S., Yazdani S., Nourani M.R. Toll-like receptors: role of inflammation and commensal bacteria. Inflamm Allergy Drug Targets 2011, 10:198-207.
12. Bae Y.S., Lee J.H., Choi S.H., Kim S., Almazan F., Witztum J.L., et al. Macrophages generate reactive oxygen species in response to minimally oxidized low-density lipoprotein: toll-like receptor 4- and spleen tyrosine kinase-dependent activation of NADPH oxidase 2. Circ Res 2009, 104:210-218. 21p following 8.
13. Jia N., Xie Q., Lin L., Gui H., Wang H., Jiang S., et al. Common variants of the TLR9 gene influence the clinical course of HBV infection. Mol Med Rep 2009, 2:277-281.
14. Innes E. Abrief history and overview of Toxoplasma gondii. Zoonoses Public Health 2010, 57:1-7.
15. Dlugonska H. Toxoplasma gondii-known and unknown parasite. Wiad Parazytol 2008, 54:199-204.
16. Hill D.E., Chirukandoth S., Dubey J. Biology and epidemiology of Toxoplasma gondii in man and animals. Animal Health Res Rev 2005, 6:41-62.
17. Furtado J.M., Winthrop K.L., Butler N.J., Smith J.R. Ocular toxoplasmosis I: parasitology, epidemiology and public health. Clin Exp Ophthalmol 2013, 41:82-94.
18. Petersen E., Kijlstra A., Stanford M. Epidemiology of ocular toxoplasmosis. Ocul Immunol Inflamm 2012, 20:68-75.
19. Torrey E.F., Yolken R.H. Toxoplasma oocysts as a public health problem. Trends Parasitol 2013, 29:380-384.
20. Meerburg B.G., Kijlstra A. Changing climate-changing pathogens: Toxoplasma gondii in North-Western Europe. Parasitol Res 2009, 105:17-24.
21. Qureshi S.T., Larivière L., Leveque G., Clermont S., Moore K.J., Gros P., et al. Endotoxin-tolerant mice have mutations in Toll-like receptor 4 (Tlr4). JExp Med 1999, 189:615-625.
22. Yamamoto M., Sato S., Hemmi H., Hoshino K., Kaisho T., Sanjo H., et al. Role of adaptor TRIF in the MyD88-independent toll-like receptor signaling pathway. Science 2003, 301:640-643.
23. Kagan J.C., Medzhitov R. Phosphoinositide-mediated adaptor recruitment controls Toll-like receptor signaling. Cell 2006, 125:943-955.
24. Kawai T., Akira S. Toll-like receptors and their crosstalk with other innate receptors in infection and immunity. Immunity 2011, 34:637-650.
25. Evans J.T., Cluff C.W., Johnson D.A., Lacy M.J., Persing D.H., Baldridge J.R. Enhancement of antigen-specific immunity via the TLR4 ligands MPL™ adjuvant and Ribi. 529. Expert Rev Vaccines 2003, 2:219-229.
26. Alderson M.R., McGowan P., Baldridge J.R., Probst P. TLR4 agonists as immunomodulatory agents. JEndotoxin Res 2006, 12:313-319.
27. Cong H., Mui E.J., Witola W.H., Sidney J., Alexander J., Sette A., et al. Human immunome, bioinformatic analyses using HLA supermotifs and the parasite genome, binding assays, studies of human T cell responses, and immunization of HLA-A*1101 transgenic mice including novel adjuvants provide a foundation for HLA-A03 restricted CD8+T cell epitope based, adjuvanted vaccine protective against Toxoplasma gondii. Immunome Res 2010, 6:12.
28. Erridge C. Endogenous ligands of TLR2 and TLR4: agonists or assistants?. JLeukoc Biol 2010, 87:989-999.
29. Cario E., Gerken G., Podolsky D. Toll-like receptor 2 controls mucosal inflammation by regulating epithelial barrier function. Gastroenterology 2007, 132:1359-1374.
30. Fitzgerald K.A., Rowe D.C., Barnes B.J., Caffrey D.R., Visintin A., Latz E., et al. LPS-TLR4 signaling to IRF-3/7 and NF-κB involves the Toll adapters TRAM and TRIF. JExp Med 2003, 198:1043-1055.
31. Lu Y.-C., Yeh W.-C., Ohashi P.S. LPS/TLR4 signal transduction pathway. Cytokine 2008, 42:145-151.
32. Furuta T., Kikuchi T., Akira S., Watanabe N., Yoshikawa Y. Roles of the small intestine for induction of toll-like receptor 4-mediated innate resistance in naturally acquired murine toxoplasmosis. Int Immunol 2006, 18:1655-1662.
33. Debierre-Grockiego F., Campos M.A., Azzouz N., Schmidt J., Bieker U., Resende M.G., et al. Activation of TLR2 and TLR4 by glycosylphosphatidylinositols derived from Toxoplasma gondii. JImmunol 2007, 179:1129-1137.
34. Niehus S., Elass E., Coddeville B., Guerardel Y., Schwarz R.T., Debierre-Grockiego F. Glycosylphosphatidylinositols of Toxoplasma gondii induce matrix metalloproteinase-9 production and degradation of galectin-3. Immunobiology 2012, 217:61-64.
35. Debierre-Grockiego F., Niehus S., Coddeville B., Elass E., Poirier F., Weingart R., et al. Binding of Toxoplasma gondii glycosylphosphatidylinositols to galectin-3 is required for their recognition by macrophages. JBiol Chem 2010, 285:32744-32750.
36. Scanga C.A., Aliberti J., Jankovic D., Tilloy F., Bennouna S., Denkers E.Y., et al. Cutting edge: MyD88 is required for resistance to Toxoplasma gondii infection and regulates parasite-induced IL-12 production by dendritic cells. JImmunol 2002, 168:5997-6001.
37. Butcher B.A., Fox B.A., Rommereim L.M., Kim S.G., Maurer K.J., Yarovinsky F., et al. Toxoplasma gondii rhoptry kinase ROP16 activates STAT3 and STAT6 resulting in cytokine inhibition and arginase-1-dependent growth control. PLoS Pathog 2011, 7:e1002236.
38. Leng J., Denkers E.Y. Toxoplasma gondii inhibits covalent modification of histone H3 at the IL-10 promoter in infected macrophages. PLoS One 2009, 4:e7589.
39. Lee E.-J., Heo Y.-M., Choi J.-H., Song H.-O., Ryu J.-S., Ahn M.-H. Suppressed production of pro-inflammatory cytokines by LPS-activated macrophages after treatment with Toxoplasma gondii lysate. Korean J Parasitol 2008, 46:145-151.
40. Bennouna S., Sukhumavasi W., Denkers E.Y. Toxoplasma gondii inhibits toll-like receptor 4 ligand-induced mobilization of intracellular tumor necrosis factor alpha to the surface of mouse peritoneal neutrophils. Infect Immun 2006, 74:4274-4281.
41. Mun H.-S., Aosai F., Norose K., Piao L.-X., Fang H., Akira S., et al. Toll-like receptor 4 mediates tolerance in macrophages stimulated with Toxoplasma gondii-derived heat shock protein 70. Infect Immun 2005, 73:4634-4642.
42. Denkers E.Y., Butcher B.A., Del Rio L., Kim L. Manipulation of mitogen-activated protein kinase/nuclear factor-kappaB-signaling cascades during intracellular Toxoplasma gondii infection. Immunol Rev 2004, 201:191-205.
43. Khan I.A., Matsuura T., Kasper L.H. IL-10 mediates immunosuppression following primary infection with Toxoplasma gondii in mice. Parasite Immunol 1995, 17:185-195.
44. Matowicka-Karna J., Dymicka-Piekarska V., Kemona H. Does Toxoplasma gondii infection affect the levels of IgE and cytokines (IL-5, IL-6, IL-10, IL-12, and TNF-alpha)?. Clin Dev Immunol 2009, 2009.
45. Wujcicka W., Wilczyński J., Nowakowska D. SNPs in toll-like receptor (TLR) genes as new genetic alterations associated with congenital toxoplasmosis?. Eur J Clin Microbiol Infect Dis 2013, 1-9.
46. Zhou Y., Wang S., Yang J., Tao J., Xu Y., Huang Y., et al. Expression of Toll-like receptor 4 in brain tissue of chronic Toxoplasma gondii infection rats and its effect on brain injury. Zhongguo xue xi chong bing fang zhi za zhi= Chinese Journal of Schistosomiasis Control 2012, 24:58.
47. Erridge C., Duncan S.H., Bereswill S., Heimesaat M.M. The induction of colitis and ileitis in mice is associated with marked increases in intestinal concentrations of stimulants of TLRs 2, 4, and 5. PLoS One 2010, 5:e9125.
48. Heimesaat M.M., Fischer A., Jahn H.-K., Niebergall J., Freudenberg M., Blaut M., et al. Exacerbation of murine ileitis by Toll-like receptor 4 mediated sensing of lipopolysaccharide from commensal Escherichia coli. Gut 2007, 56:941-948.
49. Makino M., Uemura N., Moroda M., Kikumura A., Piao L.X., Mohamed R.M., et al. Innate immunity in DNA vaccine with Toxoplasma gondii-heat shock protein 70 gene that induces DC activation and Th1 polarization. Vaccine 2011, 29:1899-1905.
50. Fang H., Mun H.S., Kikumura A., Sayama Y., Norose K., Yano A., et al. Toxoplasma gondii-derived heat shock protein 70 induces lethal anaphylactic reaction through activation of cytosolic phospholipase A2 and platelet-activating factor via Toll-like receptor 4/myeloid differentiation factor 88. Microbiol Immunol 2008, 52:366-374.
51. Aosai F., Pena M.S.R., Mun H.-S., Fang H., Mitsunaga T., Norose K., et al. Toxoplasma gondii-derived heat shock protein 70 stimulates maturation of murine bone marrow-derived dendritic cells via Toll-like receptor 4. Cell Stress Chaperones 2006, 11:13.